Breast Imaging

What Is the Right First Imaging Test for Suspicious Nipple Discharge in Pregnancy?

·
What Is the Right First Imaging Test for Suspicious Nipple Discharge in Pregnancy?

It’s a busy afternoon in the clinic when you see your next patient: a 32-year-old female, 26 weeks pregnant with her second child, who reports a new, spontaneous, bloody discharge from her right nipple for the past week. She is understandably anxious, and while physiologic changes are common during pregnancy, a unilateral, bloody discharge requires a definitive workup. The immediate clinical question is which imaging study to order first to evaluate the cause while ensuring fetal safety. This article provides a focused, step-by-step workflow for this exact scenario, grounded in the American College of Radiology (ACR) Appropriateness Criteria, which rate breast ultrasound as a `Usually appropriate` initial step.

Who Fits This Clinical Scenario?

This guidance is specifically for the initial imaging workup of a pregnant female, aged 30 years or older, presenting with clinically suspicious nipple discharge. “Clinically suspicious” typically refers to discharge that is unilateral, spontaneous (not expressed), and either bloody (sanguineous), clear (serous), or pinkish (serosanguinous). The patient’s age—30 or older—is a key factor, as the background risk of breast cancer increases with age.

This workflow does not apply to several similar-but-distinct clinical situations, which have their own evaluation pathways:

  • Patient is under age 30: While the imaging choice may be similar, the pre-test probability of malignancy is different, which can alter the downstream management.
  • A palpable mass is the primary finding: If a distinct, focal breast mass is felt, the scenario shifts to the workup of a palpable lump, even if discharge is also present.
  • Discharge is physiologic: Bilateral, milky, or multicolored discharge that only occurs with breast compression is generally physiologic, especially during pregnancy, and may not require imaging unless other suspicious features are present.
  • The patient is presenting for screening: This guidance is for a symptomatic patient, not for routine breast cancer screening in an asymptomatic pregnant individual.

What Diagnoses Are You Working Up in This Scenario?

When a pregnant patient presents with suspicious nipple discharge, the imaging workup is designed to differentiate between benign and malignant causes. The differential diagnosis is broad, but the primary goal is to confidently exclude cancer while identifying common benign etiologies.

Intraductal Papilloma: This is a common cause of bloody nipple discharge. A papilloma is a small, benign, wart-like growth that projects into a breast duct. While benign, they can sometimes be associated with atypical cells or ductal carcinoma in situ (DCIS), making definitive diagnosis important.

Duct Ectasia: This condition involves the widening of a milk duct beneath the nipple, which can become blocked or clogged with fluid. It can cause nipple discharge that is often sticky and may be greenish or black, but can also be bloody, mimicking a more sinister process.

Physiologic Changes and Galactocele: Pregnancy and lactation induce profound glandular and ductal changes. Increased vascularity can lead to a small amount of bloody discharge. A galactocele, or milk-retention cyst, can also form and present with discharge, though this is more common during lactation.

Pregnancy-Associated Breast Cancer (PABC): This is the most critical diagnosis to exclude. PABC is defined as breast cancer diagnosed during pregnancy or within one year postpartum. While relatively uncommon, it can present with nipple discharge, and the physiologic density of the pregnant breast can make clinical and imaging evaluation more challenging. Any workup must be pursued with a high index of suspicion to avoid delays in diagnosis.

Why Is Breast Ultrasound the Recommended Initial Study for This Presentation?

The ACR designates breast ultrasound (US) as `Usually appropriate` for this scenario, making it the clear first-line imaging modality. The rationale is based on its diagnostic accuracy, safety profile, and suitability for the pregnant breast.

Breast ultrasound uses no ionizing radiation, making it entirely safe for the fetus. This is the paramount consideration in any imaging decision during pregnancy. Furthermore, the breast tissue in pregnant and lactating women is typically very dense and glandular, which can significantly limit the sensitivity of mammography. Ultrasound excels in this environment, providing high-resolution images of the ducts and surrounding tissue. It is highly effective at identifying intraductal masses like papillomas, characterizing ductal dilation from ectasia, and differentiating between simple cysts (like a galactocele) and complex or solid lesions that require biopsy.

Other imaging modalities are rated lower for this specific initial workup:

  • Diagnostic Mammography and Digital Breast Tomosynthesis: These are also rated `Usually appropriate` but are not the preferred first step. They involve a low dose of ionizing radiation (ACR RRL: ☢☢ 0.1-1mSv). While this dose is minimal and considered safe with proper abdominal shielding, the principle of ALARA (As Low As Reasonably Achievable) dictates using a non-radiation modality first if it is diagnostically sufficient. Mammography is typically reserved as a supplemental tool if the ultrasound is inconclusive or suspicious for malignancy.
  • Breast MRI with or without IV contrast: This is rated `Usually not appropriate`. The primary concern is the use of gadolinium-based contrast agents, which are known to cross the placenta and have an unknown, though potentially concerning, safety profile for the fetus. Therefore, contrast-enhanced MRI is avoided during pregnancy unless the potential benefit unequivocally outweighs the theoretical risk, which is rarely the case for an initial workup of nipple discharge.

What’s Next After a Breast Ultrasound? Downstream Workflow

The results of the initial breast ultrasound will guide the subsequent steps in the patient’s management. The goal is to reach a definitive diagnosis promptly.

  • If the ultrasound is negative or shows clearly benign findings: If no abnormality is seen in the retroareolar region or if findings are unequivocally benign (e.g., a simple cyst or uncomplicated duct ectasia), the patient can typically be reassured. Close clinical follow-up for the duration of the pregnancy and postpartum period is recommended to ensure the discharge resolves or does not change in character.
  • If the ultrasound reveals an indeterminate or suspicious solid mass: Any solid intraductal mass, complex cystic lesion, or other finding suspicious for malignancy (BI-RADS 4 or 5) requires tissue sampling. The next step is an ultrasound-guided core needle biopsy. This procedure is safe during pregnancy and is the standard of care for obtaining a histologic diagnosis.
  • If the ultrasound is inconclusive: In some cases, ultrasound may show ductal dilation without a clear underlying cause. If clinical suspicion remains high, the next step is often a diagnostic mammogram (with abdominal shielding) to evaluate for calcifications or other mammographic signs of malignancy that may not be visible on ultrasound.

A positive biopsy for malignancy necessitates immediate referral to a multidisciplinary team, including a breast surgeon, medical oncologist, and maternal-fetal medicine specialist, to coordinate a treatment plan that is safe for both mother and fetus.

Pitfalls to Avoid (and When to Get Help)

Navigating this clinical scenario requires vigilance to avoid common diagnostic traps. The most significant pitfall is “diagnostic delay”—attributing suspicious symptoms solely to physiologic changes of pregnancy without a proper imaging workup. Any new, unilateral, bloody discharge warrants investigation.

Another pitfall is failing to perform a thorough, targeted ultrasound of the retroareolar region, as this is where most causative pathologies for nipple discharge are located. Similarly, if mammography is deemed necessary, ensure the facility is experienced with imaging pregnant patients and uses appropriate abdominal shielding. Finally, do not defer a necessary biopsy due to pregnancy; ultrasound-guided core needle biopsy is a safe and essential diagnostic tool.

If imaging reveals a BI-RADS 4 or 5 lesion, escalate care immediately by referring the patient to a breast surgeon for consultation and biopsy planning.

Related ACR Topics and Tools

This article covers one specific clinical variant. For a comprehensive overview of all scenarios related to breast imaging during pregnancy, or to explore the tools used to make these evidence-based decisions, the following resources are essential.

Frequently Asked Questions

Is it ever appropriate to order a mammogram first for this presentation?

While breast ultrasound is the recommended initial study, diagnostic mammography is also rated ‘Usually Appropriate’ by the ACR. It is typically used as a second-line study if the ultrasound is negative or inconclusive but clinical suspicion remains high. The primary reason to start with ultrasound is to avoid ionizing radiation, however minimal, and because ultrasound performs better in the dense breast tissue common during pregnancy.

What makes nipple discharge ‘clinically suspicious’ during pregnancy?

Suspicious features include discharge that is spontaneous (occurs without squeezing), unilateral (from one breast only), persistent, and comes from a single duct. The character of the fluid is also key: bloody (sanguineous), clear (serous), or pinkish (serosanguinous) discharge is more concerning than milky or multicolored discharge.

Why is breast MRI rated ‘Usually Not Appropriate’ in this scenario?

The main limitation of breast MRI during pregnancy is the need for a gadolinium-based contrast agent for most indications. Gadolinium is known to cross the placenta and enter the fetal circulation, and its effects on the developing fetus are not fully understood. Therefore, it is avoided unless the potential diagnostic benefit is critical and outweighs the theoretical risks, which is not the case for an initial evaluation of nipple discharge.

How does the workup change if the pregnant patient is under 30 years old?

The initial imaging choice remains the same: breast ultrasound is the recommended first step. However, the pre-test probability of malignancy is lower in women under 30. While the workup for a suspicious finding would be similar (i.e., biopsy), the threshold for further investigation of a non-specific finding might be different, and the differential diagnosis would more heavily favor benign causes like papillomas or physiologic changes.

If a biopsy is needed, is it safe to perform during pregnancy?

Yes, an ultrasound-guided core needle biopsy is considered safe to perform at any stage of pregnancy. It is a minimally invasive procedure performed with local anesthetic (like lidocaine), which has a long track record of safety. It is the standard of care for obtaining a tissue diagnosis for a suspicious breast lesion found during pregnancy.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026